Xifa Zhou

Changzhou, 213000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

SOX17-mediated MALAT1-miR-199a-HIF1α axis confers sensitivity in esophageal squamous cell carcinoma cells to radiotherapy.

SOX17-mediated MALAT1-miR-199a-HIF1α axis confers sensitivity in esophageal squamous cell carcinoma cells to radiotherapy.

Journal: Cell death discovery

Published: December 02, 2021

TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells.

TRIM13 inhibited cell proliferation and induced cell apoptosis by regulating NF-κB pathway in non-small-cell lung carcinoma cells.

Journal: Gene

Published: April 29, 2019

REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.

REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2.

Journal: Cancer science

Published: October 30, 2018

Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway.

Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway.

Journal: American journal of translational research

Published: October 14, 2018

DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer.

DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer.

Journal: Oncology reports

Published: July 07, 2017

mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.

mRNA and methylation profiling of radioresistant esophageal cancer cells: the involvement of Sall2 in acquired aggressive phenotypes.

Journal: Journal of Cancer

Published: March 26, 2016

Erratum to: Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.

Erratum to: Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 26, 2016

Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy.

Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy.

Journal: Oncology letters

Published: January 17, 2016

Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.

Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2015

Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma.

Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma.

Journal: Oncology letters

Published: June 30, 2015

High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.

High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis.

Journal: The International journal of biological markers

Published: May 19, 2015

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia.

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia.

Journal: Scientific reports

Published: February 24, 2015

Showing 1-12 of 28

Last Updated: 09/26/2026